<?xml version="1.0" encoding="UTF-8"?>
<p>Biomarkers play a pivotal role in disease screening, diagnosis, therapeutic monitoring and prognosis. Because most biomarkers used in the clinical setting are not satisfactory due to their limited specificity and sensitivity [
 <xref ref-type="bibr" rid="B1">1</xref>], an enormous effort has been made to screen and characterize new disease biomarkers during the past several decades. Recently, advances in proteomic technology, with high-throughput as its characteristics, have presented new possibilities to detect disease biomarkers.
</p>
